Mika Reiner Mayer

Partner
Full contact info

Experience

Myovant Sciences Acquired by Sumitovant Biopharma

November 4, 2022

Cooley has worked with Myovant Sciences since 2017 to develop and prosecute its owned and licensed patent portfolios and in intellectual property diligence leading up to Myovant’s acquisition by biopharmaceutical company, Sumitovant Biopharma. The total transaction value was $1.7 billion, with a total company value of $2.9 billion. Myovant aspires to redefine care for women and men through purpose-driven science, empowering medicines, and transformative advocacy.

"Myovant's two products, ORGOVYX® and MYFEMBREE® have substantial potential. We believe the combination of Sumitovant and Myovant will strengthen Myovant's product capabilities and help continue to deliver innovative therapies addressing unmet patient needs in prostate cancer and women's health," said Hiroshi Nomura, CEO of Sumitomo Pharma. "

Related contacts

Mika Reiner Mayer
Partner, Palo Alto
Kimberly Bolin
Patent Agent, Palo Alto

Avidity Biosciences – $100 Million Series C

November 13, 2019

Cooley advised Avidity Biosciences on its $100 million Series C financing round. Lawyers Josh Seidenfeld, Matt Fleming, Jeremy Gentile and Darwin Ng led the Cooley team advising the company. Avidity is pioneering antibody-oligonucleotide conjugates for the treatment of rare muscle disorders and other serious diseases. The company’s lead research program addresses myotonic dystrophy type I, a disease with no approved treatment options. 

Read more

Related contacts

Josh Seidenfeld
Partner, Palo Alto
Jeremy Gentile
Associate, San Diego
Natasha Leskovsek
Of Counsel, Washington DC
Mika Reiner Mayer
Partner, Palo Alto
Megan Browdie
Partner, Washington DC
Karen Tsai
Special Counsel, Washington DC
Kristin Peardon
Paralegal Specialist, Palo Alto
Madhuri Roy
Partner, Palo Alto

Related Practices & Industries

Arena Pharmaceuticals Agrees to Sell to Pfizer for $6.7 Billion

December 15, 2021

Cooley advised Arena Pharmaceuticals, a clinical-stage company developing innovative potential therapies for the treatment of several immuno-inflammatory diseases, on its definitive agreement to sell to Pfizer for $6.7 billion. Partners Jamie Leigh, Kevin Cooper and Steve Przesmicki led the Cooley team advising Arena.

Read more

Related contacts

Jamie Leigh
Partner, San Francisco
Kevin Cooper
Partner, New York
Steve Przesmicki
Partner, San Diego
Jacqueline Grise
Partner, Washington DC
Jeffrey J. Tolin
Partner, New York
Alexander Israel
Partner in Charge – Brussels, Brussels
Barbara Mirza
Partner, Los Angeles Santa Monica
Peter Adams
Partner, San Diego
Phil Mitchell
Partner, New York
Mika Reiner Mayer
Partner, Palo Alto
Natasha Leskovsek
Of Counsel, Washington DC
Matthew D. Silverman
Special Counsel, San Diego
Christine Graham
Special Counsel, London
Stella Sarma
Special Counsel, Brussels
Asa Henin
Special Counsel, San Diego
Sangitha Palaniappa
Associate, Palo Alto
Heidi E. Wang
Associate, San Diego
Peter Burns
Of Counsel, Palo Alto
Eileen Leman
Associate, Los Angeles Downtown
Ross Eberly
Partner, Los Angeles Santa Monica
Kyrsten Lundh
Associate, San Diego
Patrick Sharma
Associate, Los Angeles Santa Monica
Allison Kutner
Associate, New York
Andrew Epstein
Special Counsel, Seattle
Dionne A. Thomas
Associate, San Diego
Madhuri Roy
Partner, Palo Alto

Related Practices & Industries

Genesis MedTech Acquires Drug Device Asset From TriReme Medical

September 14, 2020

Cooley advised Singapore-headquartered Genesis MedTech International on its acquisition of the Chocolate Touch drug-coated balloon from TriReme Medical, a wholly owned subsidiary of Singapore-listed QT Vascular. The Chocolate Touch drug-coated balloon is the world's first balloon catheter that combines therapeutic agent delivery with the next generation of controlled dilation angioplasty technique for the treatment of peripheral vascular diseases. Cooley partners Lila Hope and Matthew Bartus led the team advising Genesis MedTech.

Related contacts

Lila Hope
Partner, Palo Alto
Matthew Bartus
Partner, San Francisco
Robert Eisenbach
Of Counsel, San Francisco
Rick Jantz
Associate, Los Angeles Santa Monica
Christopher Kimball
Partner, Washington DC
Xander Lee
Partner, Los Angeles Santa Monica
Natasha Leskovsek
Of Counsel, Washington DC
Nicola Maguire
Partner, London
Mika Reiner Mayer
Partner, Palo Alto
John Paul Oleksiuk
Partner, New York
Rama Padmanabhan
Partner, San Diego

Related Practices & Industries

Avidity Biosciences - $289 Million IPO

June 16, 2020

Cooley advised the underwriters on Avidity’s $289.1 million initial public offering of 16,560,000 shares of common stock, including full exercise of the underwriters’ option to purchase additional shares. Cowen, SVB Leerink, Credit Suisse and Wells Fargo acted as joint book-running managers. Avidity’s securities now trade on the Nasdaq Global Market under the symbol “RNA”. Partners Rich Segal, Charlie Kim and Div Gupta led the Cooley team.

Related contacts

Richard Segal
Partner, New York
Charlie Kim
Partner, San Diego
Div Gupta
Partner, New York
Grady Chang
Associate, Los Angeles Santa Monica
Mika Reiner Mayer
Partner, Palo Alto
Madhuri Roy
Partner, Palo Alto
Natasha Leskovsek
Of Counsel, Washington DC
Phil Mitchell
Partner, New York
Jennifer Shanley
Special Counsel, New York
Barbara Mirza
Partner, Los Angeles Santa Monica
Barbara Mirza
Partner, Los Angeles Santa Monica
Andrew Epstein
Special Counsel, Seattle
Stephanie Gentile
Partner, New York
Amanda Pacheco
Associate, Palo Alto
Rebecca Ross
Special Counsel, Washington DC
Darren DeStefano
Partner, Reston
Will Cai
Partner, Hong Kong

Related Practices & Industries

View more

Rankings & accolades

The Legal 500 US: Hall of Fame for Patents: Prosecution (Including Re-Examination And Post-Grant Proceedings) (2023)

Business Today: 10 Most Influential Intellectual Property Attorneys in California’s Patent Prosecution

Chambers USA: Band 1 for Intellectual Property: Patent Prosecution – California (2022 – 2023)

Chambers USA: Intellectual Property: Patent Prosecution – California (2020 – 2021)

Chambers USA: Life Sciences: IP/Patent Litigation – California (2020 – 2023)

Daily Journal: Named Among Top IP Lawyers, Top Women Lawyers, Top 25 IP Portfolio Managers

Euromoney Legal Media Group: Best in Patent

Fellows of the American Bar Foundation: Elected Member

IAM Patent 1000: Leading Patent Professional

LMG Life Sciences: Life Sciences Star, "Patent Strategy Attorney of the Year" (Winner, 2019; Finalist, 2020 - 2022)

Managing Intellectual Property: Top 250 Women in IP, IP Star

National Diversity Council: Most Powerful and Influential Women

The National Law Journal: Intellectual Property Trailblazers 

The Recorder: Women Leaders in Tech Law

Silicon Valley Business Journal: Silicon Valley Women of Influence

Memberships & affiliations

American Bar Association

Silicon Valley Intellectual Property Law Association

Cooley Protect

Empowering entrepreneurs and growth companies

Learn more

Mika’s prosecution and advice counseling is some of the best I have ever seen.

– Peer review, LMG Life Sciences